Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer.

Mol Cancer · 2021 · PMC7901210 · PMID 33622313

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

We further expanded the validation cohort and found that the OS of patients with low ITH has an increasing trend in MSKCC’s pan-cancer cohort (Additional file 2 : Fig.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.